137 related articles for article (PubMed ID: 10671483)
1. Studies on the interleukin-6-type cytokine signal transducer gp130 reveal a novel mechanism of receptor activation by monoclonal antibodies.
Müller-Newen G; Küster A; Wijdenes J; Schaper F; Heinrich PC
J Biol Chem; 2000 Feb; 275(7):4579-86. PubMed ID: 10671483
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-6 signal transducer gp130 has specific binding sites for different cytokines as determined by antagonistic and agonistic anti-gp130 monoclonal antibodies.
Wijdenes J; Heinrich PC; Müller-Newen G; Roche C; Gu ZJ; Clément C; Klein B
Eur J Immunol; 1995 Dec; 25(12):3474-81. PubMed ID: 8566040
[TBL] [Abstract][Full Text] [Related]
3. Ligand-specific utilization of the extracellular membrane-proximal region of the gp130-related signalling receptors.
Hammacher A; Wijdenes J; Hilton DJ; Nicola NA; Simpson RJ; Layton JE
Biochem J; 2000 Jan; 345 Pt 1(Pt 1):25-32. PubMed ID: 10600635
[TBL] [Abstract][Full Text] [Related]
4. gp130 transducing receptor cross-linking is sufficient to induce interleukin-6 type responses.
Fourcin M; Chevalier S; Guillet C; Robledo O; Froger J; Pouplard-Barthelaix A; Gascan H
J Biol Chem; 1996 May; 271(20):11756-60. PubMed ID: 8662709
[TBL] [Abstract][Full Text] [Related]
5. Importance of the membrane-proximal extracellular domains for activation of the signal transducer glycoprotein 130.
Kurth I; Horsten U; Pflanz S; Timmermann A; Küster A; Dahmen H; Tacken I; Heinrich PC; Müller-Newen G
J Immunol; 2000 Jan; 164(1):273-82. PubMed ID: 10605021
[TBL] [Abstract][Full Text] [Related]
6. The immunoglobulin-like module of gp130 is required for signaling by interleukin-6, but not by leukemia inhibitory factor.
Hammacher A; Richardson RT; Layton JE; Smith DK; Angus LJ; Hilton DJ; Nicola NA; Wijdenes J; Simpson RJ
J Biol Chem; 1998 Aug; 273(35):22701-7. PubMed ID: 9712900
[TBL] [Abstract][Full Text] [Related]
7. Two different epitopes of the signal transducer gp130 sequentially cooperate on IL-6-induced receptor activation.
Pflanz S; Kurth I; Grötzinger J; Heinrich PC; Müller-Newen G
J Immunol; 2000 Dec; 165(12):7042-9. PubMed ID: 11120832
[TBL] [Abstract][Full Text] [Related]
8. Activation of the signal transducer glycoprotein 130 by both IL-6 and IL-11 requires two distinct binding epitopes.
Kurth I; Horsten U; Pflanz S; Dahmen H; Küster A; Grötzinger J; Heinrich PC; Müller-Newen G
J Immunol; 1999 Feb; 162(3):1480-7. PubMed ID: 9973404
[TBL] [Abstract][Full Text] [Related]
9. Activation of the signal transducer gp130 by interleukin-11 and interleukin-6 is mediated by similar molecular interactions.
Dahmen H; Horsten U; Küster A; Jacques Y; Minvielle S; Kerr IM; Ciliberto G; Paonessa G; Heinrich PC; Müller-Newen G
Biochem J; 1998 May; 331 ( Pt 3)(Pt 3):695-702. PubMed ID: 9560294
[TBL] [Abstract][Full Text] [Related]
10. The membrane proximal cytokine receptor domain of the human interleukin-6 receptor is sufficient for ligand binding but not for gp130 association.
Ozbek S; Grötzinger J; Krebs B; Fischer M; Wollmer A; Jostock T; Müllberg J; Rose-John S
J Biol Chem; 1998 Aug; 273(33):21374-9. PubMed ID: 9694899
[TBL] [Abstract][Full Text] [Related]
11. Molecular modeling-guided mutagenesis of the extracellular part of gp130 leads to the identification of contact sites in the interleukin-6 (IL-6).IL-6 receptor.gp130 complex.
Horsten U; Müller-Newen G; Gerhartz C; Wollmer A; Wijdenes J; Heinrich PC; Grötzinger J
J Biol Chem; 1997 Sep; 272(38):23748-57. PubMed ID: 9295319
[TBL] [Abstract][Full Text] [Related]
12. Specific inhibition of IL-6 signalling with monoclonal antibodies against the gp130 receptor.
Liautard J; Sun RX; Cotte N; Gaillard JP; Mani JC; Klein B; Brochier J
Cytokine; 1997 Apr; 9(4):233-41. PubMed ID: 9112331
[TBL] [Abstract][Full Text] [Related]
13. A fusion protein of interleukin-11 and soluble interleukin-11 receptor acts as a superagonist on cells expressing gp130.
Pflanz S; Tacken I; Grötzinger J; Jacques Y; Minvielle S; Dahmen H; Heinrich PC; Müller-Newen G
FEBS Lett; 1999 Apr; 450(1-2):117-22. PubMed ID: 10350068
[TBL] [Abstract][Full Text] [Related]
14. Dimerization and activation of the common transducing chain (gp130) of the cytokines of the IL-6 family by mAb.
Autissier P; De Vos J; Liautard J; Tupitsyn N; Jacquet C; Chavdia N; Klein B; Brochier J; Gaillard JP
Int Immunol; 1998 Dec; 10(12):1881-9. PubMed ID: 9885909
[TBL] [Abstract][Full Text] [Related]
15. Activation of Fes tyrosine kinase by gp130, an interleukin-6 family cytokine signal transducer, and their association.
Matsuda T; Fukada T; Takahashi-Tezuka M; Okuyama Y; Fujitani Y; Hanazono Y; Hirai H; Hirano T
J Biol Chem; 1995 May; 270(19):11037-9. PubMed ID: 7538109
[TBL] [Abstract][Full Text] [Related]
16. Structural requirements of the interleukin-6 signal transducer gp130 for its interaction with Janus kinase 1: the receptor is crucial for kinase activation.
Haan C; Heinrich PC; Behrmann I
Biochem J; 2002 Jan; 361(Pt 1):105-11. PubMed ID: 11742534
[TBL] [Abstract][Full Text] [Related]
17. Identification of amino acid residues of gp130 signal transducer and gp80 alpha receptor subunit that are involved in ligand binding and signaling by human herpesvirus 8-encoded interleukin-6.
Li H; Nicholas J
J Virol; 2002 Jun; 76(11):5627-36. PubMed ID: 11991991
[TBL] [Abstract][Full Text] [Related]
18. Involvement of gp130/interleukin-6 receptor transducing component in interleukin-11 receptor.
Fourcin M; Chevalier S; Lebrun JJ; Kelly P; Pouplard A; Wijdenes J; Gascan H
Eur J Immunol; 1994 Jan; 24(1):277-80. PubMed ID: 8020567
[TBL] [Abstract][Full Text] [Related]
19. Analysis of the mechanism of action of anti-human interleukin-6 and anti-human interleukin-6 receptor-neutralising monoclonal antibodies.
Kalai M; Montero-Julian FA; Brakenhoff JP; Fontaine V; De Wit L; Wollmer A; Brailly H; Content J; Grötzinger J
Eur J Biochem; 1997 Nov; 249(3):690-700. PubMed ID: 9395315
[TBL] [Abstract][Full Text] [Related]
20. Anti-gp130 transducer monoclonal antibodies specifically inhibiting ciliary neurotrophic factor, interleukin-6, interleukin-11, leukemia inhibitory factor or oncostatin M.
Gu ZJ; Wijdenes J; Zhang XG; Hallet MM; Clement C; Klein B
J Immunol Methods; 1996 Mar; 190(1):21-7. PubMed ID: 8601708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
